Esprit takes eight percent in pharma merger(2)
Venture capital firm Esprit Capital Partners has acquired a Canadian drug company to merge with its existing portfolio business Kiadis Pharma.
3 January 2013•1 min read
Venture capital firm Esprit Capital Partners has acquired a Canadian drug company to merge with its existing portfolio business Kiadis Pharma.
